Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study

Aaron D. Goldberg, Ehab Atallah, David A. Rizzieri, Roland B. Walter, Ki-Young Chung, Alexander I. Spira, Wendy Stock, Martin S. Tallman, Hans G. Cruz, Joseph Boni, Karin Havenith, Grace Chao, Jay Feingold, Jens Wuerthner, Melhem Solh